Skip to content

Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints

Prevalence of Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04368416
Acronym
MEM-ASA
Enrollment
3000
Registered
2020-04-29
Start date
2020-09-22
Completion date
2024-12-31
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Alcohol Abuse, Anxiety State, Dementia, Sleep Disturbance

Brief summary

The goal of MEM-ASA is to investigate the prevalence of anxiety/depression, sleep disturbances and alcohol use disorder in elderly with cognitive complaints. In memory clinics of Normandy (France), all patients aged over 50 year-old are systematically questioned about anxiety, depression, sleep quality and alcohol use disorder. They also perform a neuropsychological assessment. Questionnaires are given to the patient and his/her caregiver to be filled in at home. Levels of anxiety/depression, sleep quality and alcohol consumption are related to neuropsychological performance, diagnosis and responses to the questionaires.

Interventions

None listed

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To have cognitive complaints * To have french as native language * Not to be opposed to be included * To be affiliated to the social security

Exclusion criteria

-To be under tutorship or curatorship

Design outcomes

Primary

MeasureTime frameDescription
Anxiety and depressionAt inclusionResponses to questions during anamnesis
Sleep qualityAt inclusionResponses to questions during anamnesis
Alcohol use disorderAt inclusionResponses to questions during anamnesis

Countries

France

Contacts

Primary ContactPierre BRANGER, MD
branger-p@chu-caen.fr33231065548
Backup ContactAnne Lise PITEL, PhD
anne-lise.pitel@unicaen.fr33231470125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026